Vanguard Health Care Adm
Name
Price
Aum/Mkt Cap
YIELD & DIV
Exp Ratio
Watchlist
Vitals
YTD Return
-11.7%
1 yr return
0.1%
3 Yr Avg Return
13.7%
5 Yr Avg Return
9.3%
Net Assets
$46.2 B
Holdings in Top 10
44.1%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 0.25%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 15.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$50,000
IRA
N/A
Fund Classification
Fund Type
Open End Mutual Fund
Investment Style
Health
Name
Price
Aum/Mkt Cap
YIELD & DIV
Exp Ratio
Watchlist
VGHAX - Profile
Distributions
- YTD Total Return -11.7%
- 3 Yr Annualized Total Return 13.7%
- 5 Yr Annualized Total Return 9.3%
- Capital Gain Distribution Frequency N/A
- Net Income Ratio 0.86%
- Dividend Yield 0.1%
- Dividend Distribution Frequency N/A
Fund Details
-
Legal NameVanguard Health Care Fund
-
Fund Family NameVanguard
-
Inception DateNov 12, 2001
-
Shares OutstandingN/A
-
Share ClassInst
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerJean Hynes
Fund Description
The fund invests at least 80% of its assets in the stocks of companies principally engaged in the development, production, or distribution of products and services related to the health care industry. These companies include, among others, pharmaceutical firms, medical supply companies, and businesses that operate hospitals and other health care facilities. The adviser may also consider companies engaged in medical, diagnostic, biochemical, and other research and development activities. The fund may invest up to 50% of its assets in foreign stocks. It is non-diversified.
VGHAX - Performance
Return Ranking - Trailing
| Period | VGHAX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -11.7% | -39.5% | 25.3% | 41.18% |
| 1 Yr | 0.1% | -60.2% | 33.9% | 32.16% |
| 3 Yr | 13.7%* | -10.0% | 19.7% | 26.17% |
| 5 Yr | 9.3%* | -6.4% | 16.9% | 60.14% |
| 10 Yr | 14.1%* | 6.4% | 18.5% | 46.03% |
* Annualized
Return Ranking - Calendar
| Period | VGHAX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2021 | 5.4% | -79.9% | 25.9% | 36.07% |
| 2020 | 3.6% | -13.6% | 178.2% | 88.89% |
| 2019 | 9.3% | 3.8% | 63.8% | 97.93% |
| 2018 | -7.3% | -49.7% | 21.5% | 51.82% |
| 2017 | 11.2% | -59.8% | 54.4% | 79.26% |
Total Return Ranking - Trailing
| Period | VGHAX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -11.7% | -46.5% | 25.3% | 40.27% |
| 1 Yr | 0.1% | -60.2% | 31.1% | 36.49% |
| 3 Yr | 13.7%* | -15.9% | 20.0% | 29.44% |
| 5 Yr | 9.3%* | -7.4% | 16.9% | 61.49% |
| 10 Yr | 14.1%* | 6.4% | 18.5% | 42.65% |
* Annualized
Total Return Ranking - Calendar
| Period | VGHAX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2021 | 5.4% | -79.9% | 25.9% | 36.07% |
| 2020 | 3.6% | -13.6% | 178.2% | 88.89% |
| 2019 | 9.3% | 3.8% | 63.8% | 97.93% |
| 2018 | -7.3% | -49.7% | 22.2% | 57.66% |
| 2017 | 11.2% | -59.8% | 54.4% | 85.93% |
NAV & Total Return History
VGHAX - Holdings
Concentration Analysis
| VGHAX | Category Low | Category High | VGHAX % Rank | |
|---|---|---|---|---|
| Net Assets | 46.2 B | 732 K | 46.2 B | 0.53% |
| Number of Holdings | 132 | 11 | 473 | 17.14% |
| Net Assets in Top 10 | 21.5 B | 2.18 K | 21.6 B | 0.82% |
| Weighting of Top 10 | 44.10% | 12.3% | 94.7% | 49.39% |
Top 10 Holdings
- UnitedHealth Group Inc 7.06%
- Pfizer Inc 6.04%
- AstraZeneca PLC 5.93%
- AstraZeneca PLC 5.93%
- AstraZeneca PLC 5.93%
- AstraZeneca PLC 5.93%
- AstraZeneca PLC 5.93%
- AstraZeneca PLC 5.93%
- AstraZeneca PLC 5.93%
- AstraZeneca PLC 5.93%
Asset Allocation
| Weighting | Return Low | Return High | VGHAX % Rank | |
|---|---|---|---|---|
| Stocks | 98.63% | 85.37% | 106.13% | 63.27% |
| Cash | 1.37% | -0.10% | 9.01% | 29.80% |
| Preferred Stocks | 0.00% | 0.00% | 7.86% | 98.78% |
| Other | 0.00% | -22.99% | 3.38% | 94.29% |
| Convertible Bonds | 0.00% | 0.00% | 0.37% | 98.78% |
| Bonds | 0.00% | 0.00% | 12.39% | 98.78% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | VGHAX % Rank | |
|---|---|---|---|---|
| Healthcare | 100.00% | 59.26% | 100.00% | 54.29% |
| Utilities | 0.00% | 0.00% | 0.00% | 98.78% |
| Technology | 0.00% | 0.00% | 22.69% | 98.78% |
| Real Estate | 0.00% | 0.00% | 7.13% | 98.78% |
| Industrials | 0.00% | 0.00% | 7.02% | 98.78% |
| Financial Services | 0.00% | 0.00% | 1.85% | 98.78% |
| Energy | 0.00% | 0.00% | 0.00% | 98.78% |
| Communication Services | 0.00% | 0.00% | 9.11% | 98.78% |
| Consumer Defense | 0.00% | 0.00% | 25.73% | 99.18% |
| Consumer Cyclical | 0.00% | 0.00% | 14.20% | 98.78% |
| Basic Materials | 0.00% | 0.00% | 14.83% | 99.18% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | VGHAX % Rank | |
|---|---|---|---|---|
| US | 73.14% | 53.67% | 104.41% | 86.94% |
| Non US | 25.49% | 0.00% | 45.40% | 11.84% |
VGHAX - Expenses
Operational Fees
| VGHAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 0.25% | 0.08% | 3.13% | 82.52% |
| Management Fee | 0.24% | 0.00% | 1.25% | 4.74% |
| 12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
| Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
| VGHAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 0.00% | 5.75% | N/A |
| Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
| VGHAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| VGHAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 15.00% | 0.00% | 238.00% | 14.47% |
VGHAX - Distributions
Dividend Yield Analysis
| VGHAX | Category Low | Category High | VGHAX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.07% | 0.00% | 3.95% | 98.80% |
Dividend Distribution Analysis
| VGHAX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Semi-Annually | Monthly | Semi-Annually |
Net Income Ratio Analysis
| VGHAX | Category Low | Category High | VGHAX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | 0.86% | -2.54% | 1.92% | 9.14% |
Capital Gain Distribution Analysis
| VGHAX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency |
Dividend Payout History
| Date | Amount | Type |
|---|---|---|
| Apr 01, 2019 | $0.050 | OrdinaryDividend |
| Dec 19, 2018 | $0.956 | OrdinaryDividend |
| Apr 02, 2018 | $0.071 | OrdinaryDividend |
| Dec 21, 2017 | $0.891 | OrdinaryDividend |
| Dec 27, 2016 | $0.828 | OrdinaryDividend |
| Dec 28, 2015 | $0.805 | OrdinaryDividend |
| Mar 27, 2015 | $0.350 | OrdinaryDividend |
| Dec 23, 2014 | $0.864 | OrdinaryDividend |
| Dec 18, 2013 | $1.021 | OrdinaryDividend |
| Dec 18, 2012 | $1.155 | OrdinaryDividend |
| Mar 22, 2012 | $0.044 | ExtraDividend |
| Mar 23, 2011 | $0.057 | ExtraDividend |
| Mar 23, 2010 | $0.039 | ExtraDividend |
| Mar 23, 2009 | $0.025 | ExtraDividend |
| Mar 28, 2008 | $0.021 | OrdinaryDividend |
| Dec 18, 2007 | $1.141 | OrdinaryDividend |
| Mar 22, 2007 | $0.066 | OrdinaryDividend |
| Dec 20, 2006 | $0.781 | OrdinaryDividend |
| Mar 27, 2006 | $0.152 | OrdinaryDividend |
| Mar 21, 2005 | $0.060 | OrdinaryDividend |
| Dec 20, 2004 | $0.502 | OrdinaryDividend |
| Mar 22, 2004 | $0.007 | OrdinaryDividend |
| Dec 22, 2003 | $0.443 | OrdinaryDividend |
| Mar 24, 2003 | $0.015 | OrdinaryDividend |
| Dec 16, 2002 | $0.410 | OrdinaryDividend |
VGHAX - Fund Manager Analysis
Managers
Jean Hynes
Start Date
Tenure
Tenure Rank
May 29, 2008
14.01
14.0%
Jean M. Hynes, CFA Chief Executive Officer, Managing Partner, and Portfolio Manager As the chief executive officer of Wellington Management Company LLP, Jean leads the firm in our mission to drive excellence for clients to positively impact millions of beneficiaries’ lives. In pursuit of that mission, she spends significant time meeting with clients globally as well as working to strengthen and support the firm’s people and capabilities. She also serves on a variety of internal management committees, including the executive, operating, and compensation committees. In addition, she is one o
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.02 | 24.72 | 6.48 | 2.12 |